Angela D’Ascola

3.3k citations
95 papers · 2.6k indexed · h-index 30

Angela D’Ascola

95 papers receiving 2.6k citations

Peers

Angela D’Ascola
Comparison fields: 5 of 126
  • Cell Biology 874
  • Rheumatology 499
  • Cancer Research 356
  • Immunology and Allergy 133
  • Physiology 99
Replace Stephen J. Getting with:
Stephen J. Getting United Kingdom
Hiroshi Sugiya Japan
Adrian C. Herington Australia
Clare Bao United States
Sadanand Fulzele United States
Gary J. Litherland United Kingdom
C. Jacques France
Krishna Singh United States
Kenneth S. Kilgore United States
Reinoud Gosens Netherlands
Angela D’Ascola relative to Stephen J. Getting United Kingdom Stephen J. Getting's profile →
Citations per field
00.5×1.5×
Stephen J. Getting · 1×
Citations per year

Countries citing papers authored by Angela D’Ascola

Since Specialization
Citations

This map shows the geographic impact of Angela D’Ascola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angela D’Ascola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angela D’Ascola more than expected).

Fields of papers citing papers by Angela D’Ascola

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angela D’Ascola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angela D’Ascola. The network helps show where Angela D’Ascola may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Angela D’Ascola, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Angela D’Ascola Line = papers co-authored together Angela D’Ascola links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20249
2 20244
3 20244
4 20233
5 20235
6 20228
7 202234
8 202017
9 201934
10 201819
11 201818
12 201820
13 20175
14 201333
15 201226
16 201272
17 201184
18 2011118
19 201021
20 200913

About Angela D’Ascola

Angela D’Ascola is a scholar working on Cell Biology, Cancer Research and Equine, having authored 95 papers that have together received 2.6k indexed citations. Recurring topics across this work include Proteoglycans and glycosaminoglycans research (43 papers), NF-κB Signaling Pathways (15 papers), MicroRNA in disease regulation (9 papers), Osteoarthritis Treatment and Mechanisms (9 papers), Immune Response and Inflammation (9 papers), Fibroblast Growth Factor Research (8 papers), Neuropeptides and Animal Physiology (5 papers) and Advanced Glycation End Products research (5 papers). The work is most often cited by research in Cell Biology (874 citations), Rheumatology (499 citations) and Cancer Research (356 citations). Angela D’Ascola has collaborated with scholars based in Italy, Spain and Russia. Frequent co-authors include Salvatore Campo, Angela Avenoso, Giuseppe M. Campo, Alberto Calatroni, Giancarlo Nastasi, Michele Scuruchi, Paola Traina, Vera Prestipino, Giuseppe Mandraffino and Antonino Saitta. Their work appears in journals such as PLoS ONE, The Science of The Total Environment and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026